SB
Singapore BIOPHARMAPTE. LTD.
Back to news
2026年1月15日HSA Approval

Singapore BIOPHARMA Announces HSA Approval for VisuECTOINE® in Singapore

Singapore BIOPHARMA PTE. LTD. announces that VisuECTOINE® has received market approval from Singapore's Health Sciences Authority (HSA).

About VisuECTOINE®

VisuECTOINE® is the TRIPLE ACTION drop for ocular irritation and allergy.

Indication: For ocular irritation and allergy (symptomatic relief)